Transcranial Navigated Magnetic Brain Stimulation



Cloud Medical and Nexstim have partnered to bring patients being treated in the UK access to the latest technology using different treatment models including Navigated Brain Stimulation (NBS). Nexstim, the developers of the NBS system have developed the use of navigated brain therapy on a non-invasive and non-surgical platform. Such system uses Transcranial Magnetic Stimulation (TMS) as a therapeutic tool to target the cortical structures of the brain believed to be involved in brain functions that alters mood and pain perception and more recently has the potential to enhance the recovery after

Together, Cloud Medical and Nexstim look forward to bringing this technological breakthrough in medical and psychiatric treatment. This alliance will see Cloud Medical working with Nexstim to explore the provision of TMS treatment for depression, chronic pain management and stroke rehabilitation

The partnership will bring about the sharing of best practice learning to deliver superior and revolutionary treatment plans for patients of different backgrounds. Cloud Medical’s first state of the art clinic is located in Bagshot, Surrey.


Navigated Brain Therapy (NBT®) delivered via TMS uses a patient’s MRI scan to identify the areas in the brain that needs targeting as identification of the painful area, the area affected by stroke and the known areas that are implicated in causing depression. Navigation is important in order to find the exact location and orientation of the area that should be treated with this magnetic stimulation. This navigated system allows to ensure precision in delivering the treatment is maintained and maximum benefit can be achieved.  TMS therapy in the UK is currently delivered through a diffused method which may decrease treatment efficacy and prolong treatment periods.



TMS stands for Transcranial Magnetic Stimulation and is also known as rTMS – Repetitive Transcranial Magnetic Stimulation. The innovative treatment is safe, effective, non-invasive and navigated therapy which is delivered through the use of magnetic pulses to the relevant parts of the brain.

TMS treatment is NICE approved (2015) for a number of psychiatric conditions and extensively researched as treatment for depression.

TMS treatment is NICE approved (2014) for the prevention and treatment of migraine.

The treatment uses a similar frequency to that of an MRI Scan.

TMS has the potential to replace electro-convulsive therapy and oral medication for depression

Non-invasive modality with promising results to date

Patient does not require any form of anaesthesia.


Transcranial Magnetic Stimulation (TMS) is a technological breakthrough in medical science. TMS is a method of brain stimulation generated by pulses of magnetic energy to either enhance or dampen brain activity in order to treat medical conditions namely depression, chronic pain and more recently stroke rehabilitation. These pulses are sent through an insulated coil which is placed over the scalp during treatment. This non-invasive and pain free treatment has been shown to be a safe and useful technique in both its therapeutic and diagnostic domain.


During a Cloud Medical TMS treatment, a unique tracker is placed over the skull initially for the technology to orient the head in space and sync it with the MRI of the person already fed into the system to help identify the target area. Subsequently an electromagnetic coil is placed over the scalp to deliver painless magnetic pulses that stimulate the targeted nerve cells in the brain which contribute to chronic pain, depression or motor dysfunction.

The magnetic pulse induces an electrical stimulation in the upper most part of the brain. This pulse induces a change in the flow of current in the cells of the brain bringing about a change in the electrical activity of the brain cells.

Navigated Brain Therapy (NBT) through rTMS is delivered at an appropriate frequency to help restore the brains natural inhibitory balance between the left and right hemisphere in the brain.

The patient remains conscious throughout the treatment delivery which can last between 30-45 minutes per session.



TMS is a generally safe procedure with over two decades of intense clinical and scientific research behind it. In 10,000 treatments during clinical trials, the most common side effects was mild to moderate scalp discomfort and mild headaches, both of which usually went away in the first week of treatment. In a very small percentage of instances there were reports of acute memory loss, minimal cognition interruption, facial twitching and seizures. These side effects were acute and TMS showed no long-term issues.

Some TMS patients may experience an effect referred to as ”The Dip”. The Dip is a possible effect which sometimes happens when the progress of your TMS Therapy is temporarily reversed. Symptoms of the Dip can include a sudden and deepening increase in depression and it can appear as though there has been an almost complete reversal of progress. For this reason, the Dip can feel very defeating and cause undue stress to a patient undergoing TMS therapy.

However it is important to remember that these effects are only temporary. People who experience this reversal in progress appear to usually gain it back.

You can download our leaflets below for the conditions we treat.


Stroke Rehabilitation Leaflet

Chronic pain management leaflet

Depression Leaflet



We are registered with all major insurance providers